PIN54 COST-EFFECTIVENESS ANALYSES (CEA) OF LOPINAVIR/RITONAVIR (LPV/R) AND ATAZANAVIR PLUS RITONAVIR (ATV VE HIV-1 INFECTED PATIENTS BASED ON CASTLE 48-WEEK STUDY- APPLICATION TO SWEDEN
Nov 1, 2010, 00:00
10.1016/S1098-3015(11)72852-2
https://www.valueinhealthjournal.com/article/S1098-3015(11)72852-2/fulltext
Title :
PIN54 COST-EFFECTIVENESS ANALYSES (CEA) OF LOPINAVIR/RITONAVIR (LPV/R) AND ATAZANAVIR PLUS RITONAVIR (ATV VE HIV-1 INFECTED PATIENTS BASED ON CASTLE 48-WEEK STUDY- APPLICATION TO SWEDEN
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)72852-2&doi=10.1016/S1098-3015(11)72852-2
First page :
A440
Section Title :
RESEARCH POSTER ABSTRACTS
Open access? :
No
Section Order :
1011